Clinical Trial Update: BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting lipid changes associated with boosted atazanavir or boosted saquinavir in HIV-infected individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atazanavir/ritonavir (atazanavir/ritonavir)
• Saquinavir/ritonavir (saquinavir/ritonavir)

Snippet

Sponsor: International Antiviral Therapy Evaluation Center | Conditions: HIV Infections | Phase 4 | Status: COMPLETED